MORPHOSYS
LIVE

Serial Number

97042228

Owner

MorphoSys AG

Attorney

Maury M. Tepper, III

Filing Date

Sep 23, 2021

Add to watchlist:

No watchlists yet
View on USPTO

MORPHOSYS Trademark

Serial Number: 97042228 • Registration: 7071326

MORPHOSYS is a trademark filed by MorphoSys AG on September 23, 2021. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

MorphoSys AG (48 trademarks)

Lena-Christ-Strasse 48
82152 Martinsried/Planegg , DE

Entity Type: 03

Trademark Details

Filing Date

September 23, 2021

Registration Date

June 6, 2023

Published for Opposition

March 21, 2023

Goods & Services

pharmaceutical preparations for the treatment of diseases that involve dysregulation of epigenetic pathways; pharmaceutical preparations for epigenetic modulators as therapeutics; pharmaceuticals comprising small molecules for the treatment and prevention of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer's, sepsis, and restenosis; small molecule compounds for use as drug delivery agents in pharmaceuticals; small molecule compounds being pharmaceuticals for the treatment and prevention of diseases and disorders, namely, metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer's, sepsis, and restenosis in humans; small molecule pharmaceuticals for the treatment of diseases and conditions, namely, metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer's, sepsis, and restenosis; Pharmaceuticals and pharmaceutical preparations for human use for the treatment and prevention of diseases and disorders, namely, metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer's, sepsis, and restenosis; antibodies sold as a component ingredient of pharmaceuticals for the treatment of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer's, sepsis, and restenosis; diagnostic preparations for medical purposes; biological substances for human medical diagnostics and analysis for the treatment of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer's, sepsis, and restenosis; Clinical medical reagents; Biological preparations for medical purposes, namely, for the treatment of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer's, sepsis, and restenosis; pharmaceutical and veterinary preparations, agents and substances for the treatment of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer's, sepsis, and restenosis

reagents for scientific and medical research for use in the research and production of small molecule pharmaceuticals; active pharmaceutical ingredients, namely, antibodies, proteins and small molecules for use in the manufacture of pharmaceuticals, biopharmaceuticals, vaccines, and finished drug products; antibodies for use in the manufacture of active ingredients of pharmaceuticals and vaccines

Pharmaceutical research and development of pharmaceutical preparations, medicines and vaccines; providing medical and scientific research information; Scientific research in the nature of conducting clinical trials for others; scientific and technological services, namely, scientific research, analysis, and testing services in the fields of analytical chemistry, biochemistry, medicinal chemistry, drug development, biotechnology, microbiology and molecular biology; research and design services, namely, research and development in the field of antibodies and clinical research in connection with the treatment and prevention of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer's, sepsis, and restenosis

Filing History

TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 21, 2025 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Mar 21, 2025 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 21, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 21, 2025 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Mar 21, 2025 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Mar 21, 2025 COAR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jun 6, 2023 NRCC
REGISTERED-PRINCIPAL REGISTER
Jun 6, 2023 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 21, 2023 NPUB
PUBLISHED FOR OPPOSITION
Mar 21, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 1, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 13, 2023 CNSA
EXAMINER'S AMENDMENT ENTERED
Feb 10, 2023 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Feb 10, 2023 GNEN
EXAMINERS AMENDMENT E-MAILED
Feb 10, 2023 GNEA
EXAMINERS AMENDMENT -WRITTEN
Feb 10, 2023 CNEA
EXAMINER'S AMENDMENT ENTERED
Feb 1, 2023 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Feb 1, 2023 GNEN
EXAMINERS AMENDMENT E-MAILED
Feb 1, 2023 GNEA
EXAMINERS AMENDMENT -WRITTEN
Feb 1, 2023 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 10, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 10, 2023 CRFA
ASSIGNED TO LIE
Jan 9, 2023 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 11, 2022 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 27, 2022 GNRN
NON-FINAL ACTION E-MAILED
Jun 27, 2022 GNRT
NON-FINAL ACTION WRITTEN
Jun 27, 2022 CNRT
ASSIGNED TO EXAMINER
Jun 24, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 25, 2021 NWOS
NEW APPLICATION ENTERED
Sep 27, 2021 NWAP